disopyramide has been researched along with Tachyarrhythmia in 141 studies
Disopyramide: A class I anti-arrhythmic agent (one that interferes directly with the depolarization of the cardiac membrane and thus serves as a membrane-stabilizing agent) with a depressant action on the heart similar to that of guanidine. It also possesses some anticholinergic and local anesthetic properties.
disopyramide : A monocarboxylic acid amide that is butanamide substituted by a diisopropylamino group at position 4, a phenyl group at position 2 and a pyridin-2-yl group at position 2. It is used as a anti-arrhythmia drug.
Excerpt | Relevance | Reference |
---|---|---|
"The role of provocation tests for the assessment of amiodarone therapy in patients with ventricular tachycardia remains a subject of controversy: recent studies seem to show that the ability to initiate VT in patients on amiodarone is compatible with a good long-term result." | 9.05 | [Value of provocation tests in the evaluation of the treatment of ventricular tachycardias with amiodarone]. ( Bounhoure, JP; Calazel, J; Cassagneau, B; Fauvel, JM; Marin, T; Massabuau, P; Narula, OS; Puel, J; Tournadre, P, 1984) |
"Disopyramide (B 712) was tested in 39 patients with chronic arrhythmias of different kind: 23 cases with atrial fibrillation, 16 cases with ventricular ectopic beats, two cases with supraventricular tachycardias." | 9.04 | [Antiarrhythmic effect of disopyramide in ventricular extrasystole and auricular fibrillation]. ( Breithardt, G; Haerten, K; Seipel, L, 1976) |
"Patients with acute myocardial infarction admitted to open wards of three hospitals were given either oral disopyramide (100 mg four times daily) or matching placebo, prophylactically, for seven days." | 9.04 | Oral disopyramide for the prevention of arrhythmias in patients with acute myocardial infarction admitted to open wards. ( Besterman, EM; Carmichael, DJ; Gillham, AD; Griffiths, JW; Kidner, PH; Summers, GD; Zainal, N, 1977) |
"The effects of intravenously administered disopyramide phosphate were evaluated in seven patients with refractory ventricular tachycardia." | 9.04 | Efficacy of disopyramide phosphate in the treatment of refractory ventricular tachycardia. ( Mason, DT; Miller, RR; Vera, Z; Vismara, LA, 1977) |
"Methoxamine, an alpha adrenoreceptor agonist, and sleep abolished repetitive nonsustained monomorphic ventricular tachycardia in a 41-year-old man without detectable underlying heart disease." | 7.68 | Repetitive nonsustained monomorphic ventricular tachycardia aborted by methoxamine and sleep "heart rate dependent ventricular tachycardia". ( Ohe, T; Shimomura, K; Takagaki, K, 1991) |
"The purpose of our study was to assess the efficacy of Propafenon in comparison with Disopyramide in the long-term treatment of repetitive ventricular tachycardia." | 7.67 | [Comparative study on the efficacy of disopyramide and propafenone in the prevention of the recurrence of ventricular tachycardia]. ( Bomba, E; Bracchetti, D; Capucci, A; Lombardi, G; Naccarella, F; Palmieri, M, 1984) |
"A study of the efficacy of intravenous disopyramide in the conversion of supraventricular tachyarrhythmias to sinus rhythm was undertaken in a group of 23 patients with a variety of cardiological diagnoses." | 7.67 | The use of intravenous disopyramide for the conversion of supraventricular tachyarrhythmias. ( Ikram, H; Stewart, DE, 1984) |
"Intraindividual comparison of the acute response to intravenous quinidine and to intravenous disopyramide was performed in 27 patients with sustained ventricular tachycardia (VT) who underwent serial electrophysiological studies." | 7.67 | Effects of intravenous disopyramide and quinidine on normal myocardium and on the characteristics of arrhythmias: intraindividual comparison in patients with sustained ventricular tachycardia. ( Brachmann, J; Kübler, W; Lengfelder, W; Rizos, I; Schmitt, C; Senges, J; von Olshausen, K, 1987) |
"A 44-year-old woman is described in whom amiodarone, disopyramide, and quinidine, administered alone separately, induced atypical ventricular tachycardia (AVT, torsade de pointes)." | 7.66 | Atypical ventricular tachycardia (torsade de pointes) induced by amiodarone: arrhythmia previously induced by quinidine and disopyramide. ( Benhorin, J; Gottlieb, S; Keren, A; Stern, S; Tzivoni, D, 1982) |
"A 59-year-old man presented with atrial flutter and a 2:1 atrioventricular response, which, after intravenous disopyramide, became 1:1." | 7.66 | Extreme tachycardia complicating the use of disopyramide in atrial flutter. ( Miller, HC; Robertson, CE, 1980) |
"We evaluated 126 patients with inducible sustained ventricular tachyarrhythmias to assess whether the response to procainamide during electrophysiologic study could predict responses to other conventional antiarrhythmic agents and combinations of agents." | 7.66 | The response to procainamide during electrophysiologic study for sustained ventricular tachyarrhythmias predicts the response to other medications. ( Buxton, AE; Josephson, ME; Sadowski, LM; Waxman, HL, 1983) |
"A patient with ischemic cardiomyopathy and congestive heart failure was treated with disopyramide phosphate for ventricular arrhythmias." | 7.66 | Disopyramide-induced ventricular tachycardia. ( Gantz, KB; Lo, KS; Lucchesi, BR; Pitt, B; Stetson, PL, 1980) |
"The efficacy of intravenous disopyramide was studied during 200 episodes of supraventricular and ventricular arrhythmias in 160 patients, mainly presenting with acute myocardial infarction or cardiac failure." | 7.66 | Efficacy of intravenous disopyramide in acute cardiac arrhythmias. ( De Backer, M; Kahn, RJ; Stoupel, E, 1981) |
"Two cases of documented torsade de pointes ventricular tachycardia in association with the use of disopyramide are described." | 7.66 | Torsade de pointes ventricular tachycardia. A complication of disopyramide shared with quinidine. ( Colman, JM; Wald, RW; Waxman, MB, 1981) |
"Oral antiarrhythmic treatment with mexiletine and disopyramide was evaluated in 34 patients with recurrent sustained ventricular tachycardias by programmed ventricular stimulation, except in a few instances where spontaneous attacks occurred under therapy." | 7.66 | Treatment of recurrent sustained ventricular tachycardia with mexiletine and disopyramide. Control by programmed ventricular stimulation. ( Lüderitz, B; Manz, M; Nitsch, J; Steinbeck, G, 1983) |
"In a 41-year-old male with diabetes mellitus well controlled with insulin (50 units/day), hypoglycemia developed after starting disopyramide treatment (200 mg/day) for correction of tachycardia." | 7.66 | Hypoglycemic effect of disopyramide in a case of diabetes mellitus under insulin treatment. ( Taketa, K; Yamamoto, Y, 1980) |
"Two patients with atrial arrhythmias are described who developed ventricular tachyarrhythmias shortly after starting disopyramide therapy." | 7.66 | Ventricular tachyarrhythmias induced by disopyramide and other similar anti-arrhythmic drugs. ( Croft, CH; Kennelly, BM, 1981) |
"The electrophysiologic actions of disopyramide phosphate on reentrant ventricular tachycardia induced by premature ventricular stimuli were evaluated in conscious dogs 2 to 4 days after myocardial infarction." | 7.66 | Electrophysiologic effects of disopyramide phosphate on reentrant ventricular arrhythmia in conscious dogs after myocardial infarction. ( Gibson, JK; Lucchesi, BR; Patterson, E, 1980) |
"The efficacy of disopyramide in the management of sustained ventricular tachycardia (VT) or ventricular fibrillation (VF) was evaluated in 50 patients by programmed ventricular stimulation: 38 patients had coronary artery disease (16 with left ventricular aneurysm), 8 had other cardiac diseases, and 4 had no apparent heart disease." | 7.66 | Disopyramide: evaluation of electrophysiologic effects and clinical efficacy in patients with sustained ventricular tachycardia or ventricular fibrillation. ( Buxton, AE; Josephson, ME; Lerman, BB; Waxman, HL, 1983) |
"The oral administration of disopyramide for the maintenance of sinus rhythm after cardioversion from atrial fibrillation resulted in prolongation of the Q-T interval and three episodes of ventricular tachycardia with the torsade de pointes morphology." | 7.66 | Ventricular tachycardia with torsade de pointes morphology induced by oral disopyramide. ( Beck, W; Commerford, PJ, 1980) |
"By means of intracardiac recordings and programmed electrical stimulation of the heart, the combination effect of verapamil and disopyramide on induction of circus movement tachycardia was studied in 8 patients with anomalous extranodal atrioventricular (A-V) pathway." | 7.66 | Combined effect of verapamil and disopyramide on induction of circus movement tachycardia in patients with pre-excitation. ( Kawai, C; Konishi, T; Matsuda, H; Matsuyama, E; Tamamura, T, 1981) |
"We evaluated the electrophysiologic effects of disopyramide phosphate in 12 patients with the Wolff-Parkinson-White syndrome." | 7.66 | Electrophysiologic effects of disopyramide phosphate in patients with Wolff-Parkinson-White syndrome. ( Cook, L; Gallagher, JJ; Kerr, CR; Prystowsky, EN; Smith, WM, 1982) |
"A patient presenting with atypical ventricular tachycardia due to oral disopyramide given in normal doses over a period of four months is described." | 7.66 | Disopyramide induced atypical ventricular tachycardia. ( Chia, BL, 1980) |
"We performed electrophysiologic studies before and after oral administration of disopyramide phosphate, 200 mg every 6 hours, in 20 patients with atrioventricular (AV) reentrant tachycardia using a retrogradely conducting accessory pathway." | 7.66 | Effects of oral disopyramide phosphate on induction and sustenance of atrioventricular reentrant tachycardia incorporating retrograde accessory pathway conduction. ( Hung, JS; Kou, HC; Lee, YS; Wu, D, 1982) |
"An unusual ventricular tachyarrhythmia developed in a 57 year old woman with recurrent ventricular tachycardia and toxic disopyramide plasma concentrations." | 7.66 | Atypical ventricular tachycardia as a manifestation of disopyramide toxicity. ( Martin, RP; McMorrow, M; Meltzer, RS; Robert, EW, 1978) |
"The probability of absence of recurrence at 6 months was 36 +/- 11% in Group C and 55 +/- 10% in Group D (p = NS)." | 6.69 | [A randomized double-blind trial comparing cibenzoline and disopyramide in the prevention of recurrences of atrial tachyarrhythmia]. ( Baudouy, Y; Bine-Scheck, F; Cheikel, J; Dambrine, P; Flammang, D; Graux, P; Jouannon, C; Leenhardt, A; Piot, O, 1998) |
"Propafenone also showed a lower incidence of side effects." | 6.66 | Comparison of propafenone and disopyramide for treatment of chronic ventricular arrhythmias: placebo-controlled, double-blind, randomized crossover study. ( Ambrosioni, E; Bertaccini, P; Bracchetti, D; Cantelli, I; Naccarella, F; Palmieri, M, 1985) |
"Out of the 28 severe arrhythmias studied, it was the ventricular extrasystoles which benefited most from treatment (79% completely successful, while there was a lesser degree of success in treating the ventricular tachycardias (35% completely successful, 30% partially successful)." | 6.64 | [Action of injected disopyramide on ventricular arrhythmias and atrioventricular conduction]. ( Bellanger, P; Desoutter, P; Motté, G; Vogel, M; Welti, JJ, 1976) |
"Disopyramide has a selective effect on potential reentry circuits in ischemic myocardium, and prolongs refractoriness in abnormal myocardium to a greater extent than its effect on the normal ventricle." | 5.27 | Actions of disopyramide on potential reentrant pathways and ventricular tachyarrhythmias in conscious dogs during the late post-myocardial infarction phase. ( Brachmann, J; Cobbe, SM; Hoffmann, E; Kübler, W; Ritzenhoff, A; Senges, J, 1984) |
"The arrhythmia started with an atrial extrasystole arising well outside the functional refractory period of the AV node, and it could be reproduced by inflation of a balloon." | 5.26 | Ectopic atrial tachycardia on swallowing. Report on favourable effect of verapamil. ( Landmark, K; Storstein, O, 1979) |
"The relative safety and efficacy of intravenous administration of adenosine, lignocaine, disopyramide, flecainide, and sotalol for termination of stable, induced ventricular tachycardia was assessed in serial trials." | 5.06 | Relative efficacy and safety of intravenous drugs for termination of sustained ventricular tachycardia. ( Camm, AJ; Garratt, CJ; Griffith, MJ; Linker, NJ; Ward, DE, 1990) |
"Oral long-term treatment with various antiarrhythmic drugs (aprindine, mexiletine, disopyramide, amiodarone) was assessed in 82 patients with recurrent tachycardias demonstrated in the ECG using programmed ventricular stimulation." | 5.05 | [Long-term drug therapy in ventricular cardiac arrhythmias. Is an improvement of the prognosis possible?]. ( Lüderitz, B; Manz, M; Steinbeck, G, 1983) |
"The role of provocation tests for the assessment of amiodarone therapy in patients with ventricular tachycardia remains a subject of controversy: recent studies seem to show that the ability to initiate VT in patients on amiodarone is compatible with a good long-term result." | 5.05 | [Value of provocation tests in the evaluation of the treatment of ventricular tachycardias with amiodarone]. ( Bounhoure, JP; Calazel, J; Cassagneau, B; Fauvel, JM; Marin, T; Massabuau, P; Narula, OS; Puel, J; Tournadre, P, 1984) |
"Disopyramide (B 712) was tested in 39 patients with chronic arrhythmias of different kind: 23 cases with atrial fibrillation, 16 cases with ventricular ectopic beats, two cases with supraventricular tachycardias." | 5.04 | [Antiarrhythmic effect of disopyramide in ventricular extrasystole and auricular fibrillation]. ( Breithardt, G; Haerten, K; Seipel, L, 1976) |
"Patients with acute myocardial infarction admitted to open wards of three hospitals were given either oral disopyramide (100 mg four times daily) or matching placebo, prophylactically, for seven days." | 5.04 | Oral disopyramide for the prevention of arrhythmias in patients with acute myocardial infarction admitted to open wards. ( Besterman, EM; Carmichael, DJ; Gillham, AD; Griffiths, JW; Kidner, PH; Summers, GD; Zainal, N, 1977) |
"The effects of intravenously administered disopyramide phosphate were evaluated in seven patients with refractory ventricular tachycardia." | 5.04 | Efficacy of disopyramide phosphate in the treatment of refractory ventricular tachycardia. ( Mason, DT; Miller, RR; Vera, Z; Vismara, LA, 1977) |
" 2) When reversion is unsuccessful and ventricular response cannot be controlled with conventional therapy, rapid supraventricular tachyarrhythmias will often normalize in response to intravenous verapamil therapy, a calcium-blocking agent soon available for clinical use." | 4.76 | Intravenous antiarrhythmic drugs: newer aspects of therapy. ( Abbott, JA, 1982) |
"Since disopyramide was introduced 5 years ago, the therapeutic spectrum of this drug in treating patients with ventricular and atrial arrhythmias has been found to be similar to that of the other type I antiarrhythmic drugs, quinidine and procainamide." | 4.76 | Disopyramide. ( Desai, J; Morady, F; Scheinman, MM, 1982) |
"Methoxamine, an alpha adrenoreceptor agonist, and sleep abolished repetitive nonsustained monomorphic ventricular tachycardia in a 41-year-old man without detectable underlying heart disease." | 3.68 | Repetitive nonsustained monomorphic ventricular tachycardia aborted by methoxamine and sleep "heart rate dependent ventricular tachycardia". ( Ohe, T; Shimomura, K; Takagaki, K, 1991) |
"A study of the efficacy of intravenous disopyramide in the conversion of supraventricular tachyarrhythmias to sinus rhythm was undertaken in a group of 23 patients with a variety of cardiological diagnoses." | 3.67 | The use of intravenous disopyramide for the conversion of supraventricular tachyarrhythmias. ( Ikram, H; Stewart, DE, 1984) |
"The purpose of our study was to assess the efficacy of Propafenon in comparison with Disopyramide in the long-term treatment of repetitive ventricular tachycardia." | 3.67 | [Comparative study on the efficacy of disopyramide and propafenone in the prevention of the recurrence of ventricular tachycardia]. ( Bomba, E; Bracchetti, D; Capucci, A; Lombardi, G; Naccarella, F; Palmieri, M, 1984) |
" Sustained rapid ventricular tachyarrhythmias requiring cardioversion for termination were induced by double right ventricular apical extrastimuli during control, and treatment with disopyramide, quinidine, and fluocortolone." | 3.67 | Failure of corticosteroid therapy to prevent induction of ventricular tachycardia in sarcoidosis. ( Belhassen, B; Laniado, S; Pines, A, 1989) |
"The efficacy of mexiletine used alone, and in combination with a class Ia antiarrhythmic drug, was assessed in 159 previously drug-refractory patients with ventricular tachycardia (VT) during serial electrophysiologic studies and during long-term (5-year) clinical follow-up." | 3.67 | Long-term efficacy of mexiletine alone and in combination with class Ia antiarrhythmic drugs for refractory ventricular arrhythmias. ( Garan, H; McElroy, M; McGovern, B; Newell, JB; Ruskin, JN; Schoenfeld, MH; Whitford, EG, 1988) |
"Intraindividual comparison of the acute response to intravenous quinidine and to intravenous disopyramide was performed in 27 patients with sustained ventricular tachycardia (VT) who underwent serial electrophysiological studies." | 3.67 | Effects of intravenous disopyramide and quinidine on normal myocardium and on the characteristics of arrhythmias: intraindividual comparison in patients with sustained ventricular tachycardia. ( Brachmann, J; Kübler, W; Lengfelder, W; Rizos, I; Schmitt, C; Senges, J; von Olshausen, K, 1987) |
"A 59-year-old man presented with atrial flutter and a 2:1 atrioventricular response, which, after intravenous disopyramide, became 1:1." | 3.66 | Extreme tachycardia complicating the use of disopyramide in atrial flutter. ( Miller, HC; Robertson, CE, 1980) |
"In a 41-year-old male with diabetes mellitus well controlled with insulin (50 units/day), hypoglycemia developed after starting disopyramide treatment (200 mg/day) for correction of tachycardia." | 3.66 | Hypoglycemic effect of disopyramide in a case of diabetes mellitus under insulin treatment. ( Taketa, K; Yamamoto, Y, 1980) |
"A patient with ischemic cardiomyopathy and congestive heart failure was treated with disopyramide phosphate for ventricular arrhythmias." | 3.66 | Disopyramide-induced ventricular tachycardia. ( Gantz, KB; Lo, KS; Lucchesi, BR; Pitt, B; Stetson, PL, 1980) |
"The efficacy of intravenous disopyramide was studied during 200 episodes of supraventricular and ventricular arrhythmias in 160 patients, mainly presenting with acute myocardial infarction or cardiac failure." | 3.66 | Efficacy of intravenous disopyramide in acute cardiac arrhythmias. ( De Backer, M; Kahn, RJ; Stoupel, E, 1981) |
"We performed electrophysiologic studies before and after oral administration of disopyramide phosphate, 200 mg every 6 hours, in 20 patients with atrioventricular (AV) reentrant tachycardia using a retrogradely conducting accessory pathway." | 3.66 | Effects of oral disopyramide phosphate on induction and sustenance of atrioventricular reentrant tachycardia incorporating retrograde accessory pathway conduction. ( Hung, JS; Kou, HC; Lee, YS; Wu, D, 1982) |
", verapamil, disopyramide, and procainamide, on paroxysmal supraventricular tachycardia (PSVT), atrial fibrillation (Af) and atrial flutter (AF) were evaluated electrophysiologically." | 3.66 | Electrophysiologic evaluation of antiarrhythmic drugs on supraventricular tachyarrhythmias. ( Hiejima, K; Satake, S; Suzuki, F; Takahashi, M, 1983) |
"The efficacy of disopyramide in the management of sustained ventricular tachycardia (VT) or ventricular fibrillation (VF) was evaluated in 50 patients by programmed ventricular stimulation: 38 patients had coronary artery disease (16 with left ventricular aneurysm), 8 had other cardiac diseases, and 4 had no apparent heart disease." | 3.66 | Disopyramide: evaluation of electrophysiologic effects and clinical efficacy in patients with sustained ventricular tachycardia or ventricular fibrillation. ( Buxton, AE; Josephson, ME; Lerman, BB; Waxman, HL, 1983) |
"Oral antiarrhythmic treatment with mexiletine and disopyramide was evaluated in 34 patients with recurrent sustained ventricular tachycardias by programmed ventricular stimulation, except in a few instances where spontaneous attacks occurred under therapy." | 3.66 | Treatment of recurrent sustained ventricular tachycardia with mexiletine and disopyramide. Control by programmed ventricular stimulation. ( Lüderitz, B; Manz, M; Nitsch, J; Steinbeck, G, 1983) |
"We evaluated 126 patients with inducible sustained ventricular tachyarrhythmias to assess whether the response to procainamide during electrophysiologic study could predict responses to other conventional antiarrhythmic agents and combinations of agents." | 3.66 | The response to procainamide during electrophysiologic study for sustained ventricular tachyarrhythmias predicts the response to other medications. ( Buxton, AE; Josephson, ME; Sadowski, LM; Waxman, HL, 1983) |
"A 44-year-old woman is described in whom amiodarone, disopyramide, and quinidine, administered alone separately, induced atypical ventricular tachycardia (AVT, torsade de pointes)." | 3.66 | Atypical ventricular tachycardia (torsade de pointes) induced by amiodarone: arrhythmia previously induced by quinidine and disopyramide. ( Benhorin, J; Gottlieb, S; Keren, A; Stern, S; Tzivoni, D, 1982) |
" disopyramide for a supraventricular tachycardia resulted in a more serious ventricular dysrhythmia giving hypotension and this probably contributed to the development of a myocardial infarction." | 3.66 | Adverse reaction to disopyramide. ( Dibble, JB; Webster, NR, 1979) |
"An unusual ventricular tachyarrhythmia developed in a 57 year old woman with recurrent ventricular tachycardia and toxic disopyramide plasma concentrations." | 3.66 | Atypical ventricular tachycardia as a manifestation of disopyramide toxicity. ( Martin, RP; McMorrow, M; Meltzer, RS; Robert, EW, 1978) |
"Two patients with atrial arrhythmias are described who developed ventricular tachyarrhythmias shortly after starting disopyramide therapy." | 3.66 | Ventricular tachyarrhythmias induced by disopyramide and other similar anti-arrhythmic drugs. ( Croft, CH; Kennelly, BM, 1981) |
"A patient presenting with atypical ventricular tachycardia due to oral disopyramide given in normal doses over a period of four months is described." | 3.66 | Disopyramide induced atypical ventricular tachycardia. ( Chia, BL, 1980) |
"Two cases of documented torsade de pointes ventricular tachycardia in association with the use of disopyramide are described." | 3.66 | Torsade de pointes ventricular tachycardia. A complication of disopyramide shared with quinidine. ( Colman, JM; Wald, RW; Waxman, MB, 1981) |
"We evaluated the electrophysiologic effects of disopyramide phosphate in 12 patients with the Wolff-Parkinson-White syndrome." | 3.66 | Electrophysiologic effects of disopyramide phosphate in patients with Wolff-Parkinson-White syndrome. ( Cook, L; Gallagher, JJ; Kerr, CR; Prystowsky, EN; Smith, WM, 1982) |
" This arrhythmia was induced by quinidine or disopyramide therapy." | 3.66 | Ventricular pacing in atypical ventricular tachycardia. ( Benhorin, J; Corcos, P; Golhman, JM; Keren, A; Stern, S; Tzivoni, D, 1981) |
"By means of intracardiac recordings and programmed electrical stimulation of the heart, the combination effect of verapamil and disopyramide on induction of circus movement tachycardia was studied in 8 patients with anomalous extranodal atrioventricular (A-V) pathway." | 3.66 | Combined effect of verapamil and disopyramide on induction of circus movement tachycardia in patients with pre-excitation. ( Kawai, C; Konishi, T; Matsuda, H; Matsuyama, E; Tamamura, T, 1981) |
"The oral administration of disopyramide for the maintenance of sinus rhythm after cardioversion from atrial fibrillation resulted in prolongation of the Q-T interval and three episodes of ventricular tachycardia with the torsade de pointes morphology." | 3.66 | Ventricular tachycardia with torsade de pointes morphology induced by oral disopyramide. ( Beck, W; Commerford, PJ, 1980) |
"A controlled multicenter study has been carried out in 46 patients with ventricular tachyarrhythmias to define the antiarrhythmic effect of disopyramide phosphate." | 3.66 | [Therapy of ventricular tachyarrhythmia with disopyramid phosphate]. ( Engel, U; Enrico, JF; Mattmann, H; Steinbrunn, W, 1980) |
"The electrophysiologic actions of disopyramide phosphate on reentrant ventricular tachycardia induced by premature ventricular stimuli were evaluated in conscious dogs 2 to 4 days after myocardial infarction." | 3.66 | Electrophysiologic effects of disopyramide phosphate on reentrant ventricular arrhythmia in conscious dogs after myocardial infarction. ( Gibson, JK; Lucchesi, BR; Patterson, E, 1980) |
"Disopyramide phosphate was administered intravenously to 57 patients with 60 episodes of arrhythmia (21 supraventricular and 39 ventricular) as a 2 mg/kg bolus." | 3.65 | The antiarrhythmic efficacy of intravenous therapy with disopyramide phosphate. ( Deano, DA; Ehsani, AI; Mautner, RK; Rosen, KM; Sherman, RH; Wu, D, 1977) |
"The probability of absence of recurrence at 6 months was 36 +/- 11% in Group C and 55 +/- 10% in Group D (p = NS)." | 2.69 | [A randomized double-blind trial comparing cibenzoline and disopyramide in the prevention of recurrences of atrial tachyarrhythmia]. ( Baudouy, Y; Bine-Scheck, F; Cheikel, J; Dambrine, P; Flammang, D; Graux, P; Jouannon, C; Leenhardt, A; Piot, O, 1998) |
"Propafenone also showed a lower incidence of side effects." | 2.66 | Comparison of propafenone and disopyramide for treatment of chronic ventricular arrhythmias: placebo-controlled, double-blind, randomized crossover study. ( Ambrosioni, E; Bertaccini, P; Bracchetti, D; Cantelli, I; Naccarella, F; Palmieri, M, 1985) |
"Out of the 28 severe arrhythmias studied, it was the ventricular extrasystoles which benefited most from treatment (79% completely successful, while there was a lesser degree of success in treating the ventricular tachycardias (35% completely successful, 30% partially successful)." | 2.64 | [Action of injected disopyramide on ventricular arrhythmias and atrioventricular conduction]. ( Bellanger, P; Desoutter, P; Motté, G; Vogel, M; Welti, JJ, 1976) |
" Special consideration, however, must be given with regard to drug selection and dosage in order to avoid adverse effects on the mother and fetus." | 2.36 | Antiarrhythmic drug therapy during pregnancy. ( Elkayam, U; Frishman, W; Rotmensch, HH, 1983) |
" The latter, however, was taking antiarrhythmic drugs at a dosage less than that proved to be effective during electropharmacological testing." | 1.27 | [Value of a serial electropharmacologic study in survivors of a cardiac arrest secondary to ventricular tachycardia or ventricular fibrillation]. ( Delise, P; Di Pede, F; Piccolo, E; Raviele, A, 1984) |
"Disopyramide has a selective effect on potential reentry circuits in ischemic myocardium, and prolongs refractoriness in abnormal myocardium to a greater extent than its effect on the normal ventricle." | 1.27 | Actions of disopyramide on potential reentrant pathways and ventricular tachyarrhythmias in conscious dogs during the late post-myocardial infarction phase. ( Brachmann, J; Cobbe, SM; Hoffmann, E; Kübler, W; Ritzenhoff, A; Senges, J, 1984) |
" If side effects intervene that may cause continued therapy to be intolerable, changing the antiarrhythmic agent, as opposed to decreasing the dosage to an ineffective range, may be appropriate." | 1.27 | New directions in antiarrhythmic drug therapy. ( Somberg, JC, 1984) |
"Mexiletine was combined with a conventional type IA antiarrhythmic agent in 25 patients (49%)." | 1.27 | Intolerance and ineffectiveness of mexiletine in patients with serious ventricular arrhythmias. ( Bardy, GH; Fahrenbruch, CE; Graham, EL; Greene, HL; Poole, JE; Pulaski, WP; Werner, JA, 1986) |
"The arrhythmia started with an atrial extrasystole arising well outside the functional refractory period of the AV node, and it could be reproduced by inflation of a balloon." | 1.26 | Ectopic atrial tachycardia on swallowing. Report on favourable effect of verapamil. ( Landmark, K; Storstein, O, 1979) |
"Disopyramide has the advantage of being available both as an oral and an intravenous preparation and is a useful drug to be added to the list of more conventional anti-dysrhythmic agents." | 1.26 | Disopyramide--an effective treatment for lignocaine resistant ventricular dysrhythmias. ( Green, AG, 1979) |
"atrial premature beats (APBs) which were conducted to the ventricles normally or aberrantly; 2." | 1.26 | Atrial bigeminy with block associated with bradycardia and paroxysmal atrial fibrillation -- an important variant of the tachycardia-bradycardia syndrome. ( Camm, AJ; Spurrell, RA; Ward, DE; Washington, HG, 1979) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 134 (95.04) | 18.7374 |
1990's | 7 (4.96) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Rotmensch, HH | 1 |
Elkayam, U | 1 |
Frishman, W | 1 |
Prystowsky, EN | 4 |
Somberg, JC | 2 |
Kienzle, MG | 1 |
Williams, PD | 1 |
Zygmont, D | 1 |
Doherty, JU | 1 |
Josephson, ME | 6 |
Lo, KS | 1 |
Gantz, KB | 1 |
Stetson, PL | 1 |
Lucchesi, BR | 2 |
Pitt, B | 1 |
Theisen, K | 2 |
Jahrmärker, H | 1 |
Berman, ND | 1 |
De Backer, M | 1 |
Stoupel, E | 1 |
Kahn, RJ | 1 |
Zhivoderov, VM | 1 |
Zakharov, VN | 1 |
Doshchitsin, VL | 1 |
Aksenova, TN | 1 |
Andriukova, EI | 1 |
Garson, A | 1 |
Gillette, PC | 1 |
Lüderitz, B | 3 |
Levick, CE | 1 |
Mizgala, HF | 1 |
Kerr, CR | 2 |
Sevick, RJ | 1 |
Wyse, DG | 3 |
Manz, M | 2 |
Steinbeck, G | 2 |
Cassagneau, B | 1 |
Calazel, J | 1 |
Puel, J | 1 |
Massabuau, P | 1 |
Tournadre, P | 1 |
Fauvel, JM | 1 |
Bounhoure, JP | 1 |
Marin, T | 1 |
Narula, OS | 1 |
Taketa, K | 1 |
Yamamoto, Y | 1 |
Yamaguchi, A | 1 |
Kato, T | 1 |
Shimada, E | 1 |
Matsumoto, K | 1 |
Asano, H | 1 |
Yamane, Y | 1 |
Watanabe, M | 1 |
Palmieri, M | 2 |
Capucci, A | 1 |
Lombardi, G | 1 |
Naccarella, F | 2 |
Bomba, E | 1 |
Bracchetti, D | 2 |
Frucht, J | 1 |
Freimann, I | 1 |
Merin, S | 1 |
Raviele, A | 1 |
Di Pede, F | 1 |
Delise, P | 1 |
Piccolo, E | 1 |
Stewart, DE | 1 |
Ikram, H | 2 |
Cobbe, SM | 1 |
Hoffmann, E | 1 |
Ritzenhoff, A | 1 |
Brachmann, J | 2 |
Kübler, W | 2 |
Senges, J | 2 |
Romano, M | 1 |
Garbarini, U | 1 |
Cazzani, E | 1 |
Agre, K | 1 |
Komatsu, C | 1 |
Ishinaga, T | 1 |
Motoyama, M | 1 |
Marutani, K | 1 |
Teruya, H | 1 |
Nakayama, M | 1 |
Kuno, A | 1 |
Sato, Y | 1 |
Yoshimura, S | 1 |
Rinkenberger, RL | 1 |
Jackman, WM | 1 |
Naccarelli, GV | 1 |
Heger, JJ | 1 |
Zipes, DP | 1 |
Smith, WM | 1 |
Cook, L | 1 |
Gallagher, JJ | 2 |
Kou, HC | 1 |
Hung, JS | 1 |
Lee, YS | 1 |
Wu, D | 2 |
Kasanuki, H | 1 |
Ohnishi, S | 1 |
Hirosawa, K | 1 |
Yanaga, T | 1 |
Ichimaru, Y | 1 |
Ueno, T | 1 |
Hata, Y | 1 |
Okamoto, K | 1 |
Kodama, Y | 1 |
Otsuka, K | 1 |
Hiejima, K | 1 |
Suzuki, F | 1 |
Takahashi, M | 1 |
Satake, S | 1 |
Lerman, BB | 1 |
Waxman, HL | 2 |
Buxton, AE | 2 |
Nitsch, J | 1 |
Riccioni, N | 1 |
Castiglioni, M | 1 |
Bartolomei, C | 1 |
Sadowski, LM | 1 |
Koeda, T | 1 |
Ichikawa, T | 1 |
Kikuchi, H | 1 |
Chiba, S | 1 |
Matsushita, K | 1 |
Ozeki, T | 1 |
Sato, M | 1 |
Miura, S | 1 |
Saito, S | 1 |
Kawamura, A | 1 |
Yoshinaga, S | 1 |
Urabe, K | 1 |
Kawakami, M | 1 |
Orikasa, C | 1 |
Kato, M | 1 |
Neumann, G | 1 |
Grube, E | 1 |
Funke, H | 1 |
Chia, BL | 2 |
Breithardt, G | 3 |
Seipel, L | 3 |
Abendroth, RR | 1 |
Loogen, F | 1 |
Morady, F | 1 |
Scheinman, MM | 2 |
Desai, J | 1 |
Abbott, JA | 1 |
Keren, A | 4 |
Tzivoni, D | 4 |
Gottlieb, S | 3 |
Benhorin, J | 3 |
Stern, S | 4 |
Santinelli, V | 1 |
Chiariello, M | 1 |
Condorelli, M | 1 |
Welch, WJ | 1 |
Strasberg, B | 2 |
Coelho, A | 1 |
Rosen, KM | 3 |
Swiryn, S | 1 |
Bauernfeind, RA | 1 |
Palileo, E | 1 |
Iverson, N | 1 |
Levy, PS | 1 |
Feigl, D | 1 |
Ashkenazi, J | 1 |
Schwarzmann, H | 1 |
Croft, CH | 1 |
Kennelly, BM | 1 |
Wald, RW | 1 |
Waxman, MB | 1 |
Colman, JM | 1 |
Golhman, JM | 1 |
Corcos, P | 1 |
Gavish, D | 1 |
Levi, J | 1 |
Matsuda, H | 1 |
Konishi, T | 1 |
Matsuyama, E | 1 |
Tamamura, T | 1 |
Kawai, C | 1 |
Edhag, O | 1 |
Forssell, G | 1 |
Schenck-Gustafsson, K | 1 |
Sullivan, J | 1 |
Ee, B | 1 |
Oh, V | 1 |
Vajola, SF | 1 |
Chiavarelli, V | 1 |
Milazzotto, F | 1 |
Herling, IM | 1 |
Horowitz, LN | 4 |
Rothman, MT | 1 |
Porterfield, JG | 1 |
Antman, EM | 1 |
Lown, B | 1 |
Commerford, PJ | 1 |
Beck, W | 1 |
Lara, M | 1 |
Oakley, GD | 1 |
Rowbotham, D | 1 |
Steinbrunn, W | 1 |
Mattmann, H | 1 |
Enrico, JF | 1 |
Engel, U | 1 |
Vetter, VL | 1 |
Harken, AH | 1 |
Patterson, E | 1 |
Gibson, JK | 1 |
Robertson, CE | 1 |
Miller, HC | 1 |
Haerten, K | 2 |
Piot, O | 1 |
Flammang, D | 1 |
Dambrine, P | 1 |
Cheikel, J | 1 |
Jouannon, C | 1 |
Graux, P | 1 |
Baudouy, Y | 1 |
Bine-Scheck, F | 1 |
Leenhardt, A | 1 |
Donaldson, RM | 1 |
Nisbet, T | 1 |
Dreifus, LS | 1 |
Spurrell, RA | 3 |
Thorburn, CW | 1 |
Camm, J | 1 |
Sowton, E | 1 |
Deuchar, DC | 1 |
Vogel, M | 1 |
Desoutter, P | 1 |
Bellanger, P | 1 |
Motté, G | 1 |
Welti, JJ | 1 |
Zainal, N | 1 |
Carmichael, DJ | 1 |
Griffiths, JW | 1 |
Besterman, EM | 1 |
Kidner, PH | 1 |
Gillham, AD | 1 |
Summers, GD | 1 |
Siklos, P | 1 |
Chalmers, TM | 1 |
Evans, DW | 1 |
Landmark, K | 1 |
Storstein, O | 1 |
Green, AG | 1 |
Washington, HG | 1 |
Ward, DE | 2 |
Camm, AJ | 2 |
Oshrain, C | 1 |
Vismara, LA | 2 |
Vera, Z | 1 |
Miller, RR | 1 |
Mason, DT | 2 |
Benditt, DG | 1 |
Pritchett, EL | 1 |
Wallace, AG | 2 |
Koch-Weser, J | 1 |
Forester, D | 1 |
Fox, K | 1 |
Evans, T | 1 |
Rowland, E | 1 |
Krikler, D | 1 |
Dibble, JB | 1 |
Webster, NR | 1 |
Cumming, AD | 1 |
Robertson, C | 1 |
Holt, DW | 1 |
Walsh, AC | 1 |
Curry, PV | 1 |
Tynan, M | 1 |
Chan, W | 1 |
Mason, JW | 1 |
Winkle, RA | 1 |
Farshidi, A | 1 |
Spielman, SR | 2 |
Michelson, EL | 1 |
Greenspan, AM | 2 |
Meltzer, RS | 1 |
Robert, EW | 1 |
McMorrow, M | 1 |
Martin, RP | 1 |
LaBarre, A | 1 |
Strauss, HC | 1 |
Evans, GT | 1 |
Bashore, T | 1 |
Tiedeman, JS | 1 |
Jutzy, RV | 1 |
Pugh, DM | 1 |
Harner, RH | 1 |
Boyd, RB | 1 |
Deano, DA | 1 |
Mautner, RK | 1 |
Sherman, RH | 1 |
Ehsani, AI | 1 |
Haworth, E | 1 |
Burroughs, AK | 1 |
Hulting, J | 1 |
Rosenhamer, G | 1 |
Rangno, RE | 1 |
Warnica, W | 1 |
Ogilvie, RI | 1 |
Kreeft, J | 1 |
Bridger, E | 1 |
Smith, WS | 1 |
Berman, R | 1 |
Cook, WR | 1 |
He, ZS | 1 |
Komori, S | 1 |
Tamura, K | 1 |
Hashimoto, K | 1 |
Ohe, T | 2 |
Takagaki, K | 1 |
Shimomura, K | 2 |
Griffith, MJ | 1 |
Linker, NJ | 1 |
Garratt, CJ | 1 |
Waldo, AL | 1 |
Fisher, JD | 3 |
Duncan, WJ | 1 |
Tyrrell, MJ | 1 |
Bharadwaj, BB | 1 |
Suzuki, K | 2 |
Korsukewitz, J | 1 |
Wegscheider, K | 1 |
Schmutzler, H | 1 |
Kim, SG | 2 |
Seiden, SW | 1 |
Matos, JA | 1 |
Waspe, LE | 1 |
Miura, D | 1 |
Keefe, DL | 1 |
Aizawa, Y | 2 |
Funazaki, T | 1 |
Satoh, M | 1 |
Aizawa, M | 1 |
Shibata, A | 2 |
Au, PK | 1 |
Bhandari, AK | 1 |
Bream, R | 1 |
Schreck, D | 1 |
Siddiqi, R | 1 |
Rahimtoola, SH | 1 |
Willis, PW | 1 |
Ragosta, M | 1 |
Weihl, AC | 1 |
Rosenfeld, LE | 1 |
Le Corre, P | 1 |
Gibassier, D | 1 |
Descaves, C | 1 |
Sado, P | 1 |
Daubert, JC | 1 |
Le Verge, R | 1 |
Schattner, A | 1 |
Gindin, J | 1 |
Geltner, D | 1 |
Duff, HJ | 2 |
Mitchell, LB | 2 |
Nath, CF | 1 |
Manyari, DE | 1 |
Baynton, R | 1 |
Nanimatsu, H | 1 |
Shibayama, H | 1 |
Koumatsu, A | 1 |
Inoue, T | 1 |
Maeda, T | 1 |
Saikawa, T | 2 |
Ito, S | 2 |
Takaki, R | 2 |
Tsunematsu, Y | 1 |
Mercando, AD | 1 |
Tam, S | 1 |
Belhassen, B | 1 |
Pines, A | 1 |
Laniado, S | 1 |
Goedel-Meinen, L | 1 |
Hofmann, M | 1 |
Schmidt, G | 1 |
Barthel, P | 1 |
Baedeker, W | 1 |
Blömer, H | 1 |
Whitford, EG | 1 |
McGovern, B | 1 |
Schoenfeld, MH | 1 |
Garan, H | 1 |
Newell, JB | 1 |
McElroy, M | 1 |
Ruskin, JN | 1 |
Berry, NS | 1 |
Bauman, JL | 1 |
Gallastegui, JL | 1 |
Bauma, W | 1 |
Beckman, KJ | 1 |
Hariman, RJ | 1 |
Niwa, H | 1 |
Nakamura, S | 1 |
Takakura, T | 1 |
Nakagawa, M | 1 |
Fukuoka, Y | 1 |
Tamura, M | 1 |
Yonemochi, H | 1 |
Miyajima, S | 1 |
Matsuoka, A | 1 |
Okabe, M | 1 |
Rizos, I | 1 |
Lengfelder, W | 1 |
Schmitt, C | 1 |
von Olshausen, K | 1 |
Yamamoto, K | 1 |
Ikeda, K | 1 |
Kamakura, S | 1 |
Matsuhisa, M | 1 |
Sethi, KK | 1 |
Mohan, JC | 1 |
Singhal, A | 1 |
Gupta, MP | 1 |
Poole, JE | 1 |
Werner, JA | 1 |
Bardy, GH | 1 |
Graham, EL | 1 |
Pulaski, WP | 1 |
Fahrenbruch, CE | 1 |
Greene, HL | 1 |
Yasuda, M | 1 |
Toda, I | 1 |
Akioka, K | 1 |
Teragaki, M | 1 |
Oku, H | 1 |
Takeuchi, K | 1 |
Takeda, T | 1 |
Inoue, E | 1 |
Ikuno, Y | 1 |
Horiguchi, T | 1 |
Cantelli, I | 1 |
Bertaccini, P | 1 |
Ambrosioni, E | 1 |
Teichman, S | 1 |
Lisin, N | 1 |
Andriange, M | 1 |
Vandenbosch, R | 1 |
Carlier, J | 1 |
Yen, CH | 1 |
Lowrie, HS | 1 |
Dean, RR | 1 |
Amsterdam, EA | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Non-invasive Programmed Stimulation to Identify High-risk Patients With Implanted Cardioverter-defibrillator[NCT02373306] | 150 participants (Anticipated) | Interventional | 2013-11-30 | Completed | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
10 reviews available for disopyramide and Tachyarrhythmia
Article | Year |
---|---|
Antiarrhythmic drug therapy during pregnancy.
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Breast Feeding; Digitalis | 1983 |
Pharmacologic therapy of tachyarrhythmias in patients with Wolff-Parkinson-White syndrome.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Ajmaline; Amiodarone; Anilides; Aprindine; Atr | 1983 |
Antiarrhythmic drug therapy for sustained ventricular tachycardia.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Benzeneacetami | 1984 |
[Medical treatment of extrasystole and tachycardia (author's transl)].
Topics: Action Potentials; Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Bretylium Compounds; Calcium; Cardi | 1980 |
[Control of recurrent ventricular tachycardia in a case of mitral valve prolapse and arterial hypertension, using the combination of disopyramide and amiodarone].
Topics: Amiodarone; Benzofurans; Disopyramide; Drug Therapy, Combination; Female; Heart Ventricles; Humans; | 1982 |
Disopyramide.
Topics: Arrhythmias, Cardiac; Disopyramide; Drug Interactions; Electrophysiology; Heart; Heart Block; Humans | 1982 |
Intravenous antiarrhythmic drugs: newer aspects of therapy.
Topics: Anti-Arrhythmia Agents; Disopyramide; Electrocardiography; Hemodynamics; Humans; Injections, Intrave | 1982 |
The treatment of ventricular rhythm disturbances.
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Complexes, Premat | 1986 |
Combination antiarrhythmic drug therapy for ventricular tachyarrhythmias.
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; | 1986 |
The clinical scope of disopyramide seven years after introduction--an overview.
Topics: Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Disopyramide; Heart Ventricles; Humans; Tachyc | 1987 |
24 trials available for disopyramide and Tachyarrhythmia
Article | Year |
---|---|
[Long-term drug therapy in ventricular cardiac arrhythmias. Is an improvement of the prognosis possible?].
Topics: Adult; Aged; Amiodarone; Aprindine; Arrhythmias, Cardiac; Disopyramide; Humans; Long-Term Care; Mexi | 1983 |
[Value of provocation tests in the evaluation of the treatment of ventricular tachycardias with amiodarone].
Topics: Adult; Aged; Amiodarone; Benzofurans; Clinical Trials as Topic; Disopyramide; Drug Therapy, Combinat | 1984 |
Serial electrophysiological testing of antiarrhythmic drug efficacy in patients with recurrent ventricular tachycardia.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Clinical Trials as Topic; Coronary | 1980 |
[A randomized double-blind trial comparing cibenzoline and disopyramide in the prevention of recurrences of atrial tachyarrhythmia].
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Disopyramide; Double-Blind Method; Female; Humans | 1998 |
Clinical studies of Norpace (Part XI).
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Clinical Trials as Topic | 1975 |
[Action of injected disopyramide on ventricular arrhythmias and atrioventricular conduction].
Topics: Aged; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Clinical Trials as Topic; Disopyramide; Dr | 1976 |
[Antiarrhythmic effect of disopyramide in ventricular extrasystole and auricular fibrillation].
Topics: Adolescent; Adult; Aged; Atrial Fibrillation; Cardiac Complexes, Premature; Disopyramide; Electrocar | 1976 |
Oral disopyramide for the prevention of arrhythmias in patients with acute myocardial infarction admitted to open wards.
Topics: Acute Disease; Administration, Oral; Aged; Arrhythmias, Cardiac; Clinical Trials as Topic; Disopyram | 1977 |
Clinical studies of Norpace (Part IX).
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Diarrhea; Disopyramide; Drug | 1975 |
Efficacy of disopyramide phosphate in the treatment of refractory ventricular tachycardia.
Topics: Aged; Clinical Trials as Topic; Coronary Disease; Disopyramide; Drug Evaluation; Heart Failure; Huma | 1977 |
Clinical studies of Norpace (Part IV).
Topics: Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Clinical Trials as T | 1975 |
Clinical studies of Norpace (Part VI).
Topics: Adult; Anti-Arrhythmia Agents; Anticoagulants; Arrhythmias, Cardiac; Bradycardia; Clinical Trials as | 1975 |
Clinical studies of Norpace (Part I).
Topics: Administration, Oral; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Capsules; Clinical Trials as Top | 1975 |
Clinical studies of Norpace (Part VII).
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Disopyramide; Drug Evaluatio | 1975 |
Relative efficacy and safety of intravenous drugs for termination of sustained ventricular tachycardia.
Topics: Adenosine; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Clinical Trials as Topic; Disopyramid | 1990 |
Use of disopyramide by arrhythmia specialists after Cardiac Arrhythmia Suppression Trial: patient selection and initial outcome.
Topics: Arrhythmias, Cardiac; Data Collection; Delayed-Action Preparations; Disopyramide; Drug Therapy, Comb | 1991 |
[Idiopathic ventricular tachyarrhythmia. Spontaneous variability and effect of various antiarrhythmic agents].
Topics: Adult; Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Clinical Trials as Topic; Disopyramide; | 1985 |
Discordance between ambulatory monitoring and programmed stimulation in assessing efficacy of class IA antiarrhythmic agents in patients with ventricular tachycardia.
Topics: Aged; Ambulatory Care; Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Cardiac Pacing, Artific | 1985 |
Combination antiarrhythmic drug therapy for ventricular tachyarrhythmias.
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; | 1986 |
Clinical pharmacokinetics of levorotatory and racemic disopyramide, at steady state, following oral administration in patients with ventricular arrhythmias.
Topics: Administration, Oral; Adult; Aged; Cardiac Complexes, Premature; Disopyramide; Double-Blind Method; | 1989 |
[Effect of class I anti-arrhythmia agents on the signal-averaged ECG].
Topics: Anti-Arrhythmia Agents; Cardiomyopathy, Dilated; Clinical Trials as Topic; Coronary Disease; Disopyr | 1988 |
Comparison of propafenone and disopyramide for treatment of chronic ventricular arrhythmias: placebo-controlled, double-blind, randomized crossover study.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Disopyramide; D | 1985 |
The anticholinergic side effects of disopyramide and controlled-release disopyramide.
Topics: Delayed-Action Preparations; Disopyramide; Drug Interactions; Drug Therapy, Combination; Humans; Pyr | 1985 |
Disopyramide phosphate: clinical efficacy of a new oral antiarrhythmic drug.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzothiadiazines; Digoxin; Disopyramide; | 1974 |
108 other studies available for disopyramide and Tachyarrhythmia
Article | Year |
---|---|
New directions in antiarrhythmic drug therapy.
Topics: Adrenergic beta-Antagonists; Ajmaline; Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Benz | 1984 |
Disopyramide-induced ventricular tachycardia.
Topics: Alcoholism; Cardiac Complexes, Premature; Cardiomyopathies; Coronary Disease; Disopyramide; Heart Fa | 1980 |
Ventricular tachycardia initiated by both normally and aberrantly conducted atrial premature beats.
Topics: Aged; Arrhythmias, Cardiac; Bundle-Branch Block; Cardiac Complexes, Premature; Cardiac Pacing, Artif | 1980 |
Efficacy of intravenous disopyramide in acute cardiac arrhythmias.
Topics: Acute Disease; Adolescent; Adult; Aged; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; C | 1981 |
[Anti-arrhythmic effectiveness of ethmozine, cordaron and rhythmodan in treating ischemic heart disease].
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Benzofurans; Cardiac Complexes | 1981 |
Treatment of chronic ventricular dysrhythmias in the young.
Topics: Administration, Oral; Adolescent; Adult; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Child; Child, | 1981 |
[Drug therapy of arrhythmia in coronary cardiopathy].
Topics: Amiodarone; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Benzeneacetamides; Cardiac Comp | 1983 |
Failure to pace following high dose antiarrhythmic therapy--reversal with isoproterenol.
Topics: Amiodarone; Anti-Arrhythmia Agents; Disopyramide; Drug Therapy, Combination; Electrocardiography; Hu | 1984 |
Long-term management of arrhythmogenic right ventricular dysplasia.
Topics: Adolescent; Cardiomegaly; Cardiomyopathies; Disopyramide; Electrocardiography; Heart Ventricles; Hum | 1983 |
Hypoglycemic effect of disopyramide in a case of diabetes mellitus under insulin treatment.
Topics: Adult; Diabetes Complications; Diabetes Mellitus; Disopyramide; Humans; Hypoglycemia; Insulin; Male; | 1980 |
[A case of atypical ventricular tachycardia induced by disopyramide].
Topics: Disopyramide; Heart Block; Humans; Male; Tachycardia | 1984 |
[Comparative study on the efficacy of disopyramide and propafenone in the prevention of the recurrence of ventricular tachycardia].
Topics: Anti-Arrhythmia Agents; Disopyramide; Drug Evaluation; Heart Ventricles; Humans; Propafenone; Propio | 1984 |
Ocular side effects of disopyramide.
Topics: Accommodation, Ocular; Adolescent; Disopyramide; Eye Diseases; Female; Humans; Paralysis; Pupil; Tac | 1984 |
[Value of a serial electropharmacologic study in survivors of a cardiac arrest secondary to ventricular tachycardia or ventricular fibrillation].
Topics: Adult; Aged; Amiodarone; Death, Sudden; Disopyramide; Drug Therapy, Combination; Electrocardiography | 1984 |
The use of intravenous disopyramide for the conversion of supraventricular tachyarrhythmias.
Topics: Adolescent; Adult; Aged; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Disopyramide; Dr | 1984 |
Actions of disopyramide on potential reentrant pathways and ventricular tachyarrhythmias in conscious dogs during the late post-myocardial infarction phase.
Topics: Animals; Cardiac Pacing, Artificial; Disopyramide; Dogs; Electrocardiography; Electrodes; Infusions, | 1984 |
Corrected data on disopyramide phosphate (Norpace)
Topics: Disopyramide; Drug Labeling; Humans; Organophosphorus Compounds; Pyridines; Tachycardia | 1981 |
[Induction and termination of ventricular tachycardia by programmed electrical stimulation of heart--a case in which the effect of disopyramide phosphate was confirmed by the stimulation study (author's transl)].
Topics: Administration, Oral; Adolescent; Cardiac Pacing, Artificial; Disopyramide; Electric Stimulation; Hu | 1981 |
Drug conversion of nonsustained ventricular tachycardia to sustained ventricular tachycardia during serial electrophysiologic studies: identification of drugs that exacerbate tachycardia and potential mechanisms.
Topics: Adult; Aged; Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Cardiac Catheterization; Disop | 1982 |
Electrophysiologic effects of disopyramide phosphate in patients with Wolff-Parkinson-White syndrome.
Topics: Administration, Oral; Adolescent; Adult; Atrial Fibrillation; Disopyramide; Electrocardiography; Fem | 1982 |
Effects of oral disopyramide phosphate on induction and sustenance of atrioventricular reentrant tachycardia incorporating retrograde accessory pathway conduction.
Topics: Administration, Oral; Adolescent; Adult; Aged; Atrioventricular Node; Disopyramide; Female; Heart Co | 1982 |
Availability of electrophysiological approach to the selection and assessment of antiarrhythmic drugs for recurrent ventricular tachycardia.
Topics: Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Disopyramide; Electric Stimulation; Electrocardiogr | 1983 |
The usefulness of Holter monitoring in the evaluation of antiarrhythmic drug efficacy for tachycardia.
Topics: Adult; Aged; Angina Pectoris, Variant; Anti-Arrhythmia Agents; Diltiazem; Disopyramide; Female; Hear | 1983 |
Electrophysiologic evaluation of antiarrhythmic drugs on supraventricular tachyarrhythmias.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Atrioventricular Node; Disopyramide; El | 1983 |
Disopyramide: evaluation of electrophysiologic effects and clinical efficacy in patients with sustained ventricular tachycardia or ventricular fibrillation.
Topics: Adult; Aged; Cardiac Pacing, Artificial; Disopyramide; Electrocardiography; Female; Heart Ventricles | 1983 |
Treatment of recurrent sustained ventricular tachycardia with mexiletine and disopyramide. Control by programmed ventricular stimulation.
Topics: Adult; Aged; Cardiac Pacing, Artificial; Disopyramide; Female; Humans; Male; Mexiletine; Middle Aged | 1983 |
Disopyramide-induced QT prolongation and ventricular tachyarrhythmias.
Topics: Aged; Disopyramide; Electrocardiography; Female; Heart Ventricles; Humans; Pyridines; Tachycardia | 1983 |
The response to procainamide during electrophysiologic study for sustained ventricular tachyarrhythmias predicts the response to other medications.
Topics: Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Disopyramide; Drug Ther | 1983 |
[A case of ventricular tachycardia with non-ischemic apical aneurysm].
Topics: Adult; Disopyramide; Female; Heart Aneurysm; Heart Ventricles; Humans; Propranolol; Tachycardia | 1983 |
[The value of antitachycardia pacemaker therapy in patients with Wolff-Parkinson-White syndrome].
Topics: Anti-Arrhythmia Agents; Bundle of His; Digitalis Glycosides; Disopyramide; Electrocardiography; Huma | 1983 |
Disopyramide induced atypical ventricular tachycardia.
Topics: Administration, Oral; Aged; Arrhythmias, Cardiac; Disopyramide; Electrocardiography; Female; Heart V | 1980 |
Atypical ventricular tachycardia (torsade de pointes) induced by amiodarone: arrhythmia previously induced by quinidine and disopyramide.
Topics: Adult; Amiodarone; Atrial Fibrillation; Benzofurans; Disopyramide; Dose-Response Relationship, Drug; | 1982 |
Torsade de pointes.
Topics: Aged; Disopyramide; Electrocardiography; Female; Heart Ventricles; Humans; Tachycardia | 1982 |
Sustained macroreentrant ventricular tachycardia.
Topics: Aged; Amiodarone; Disopyramide; Electrocardiography; Heart Conduction System; Humans; Male; Procaina | 1982 |
Prediction of response to class I antiarrhythmic drugs during electrophysiologic study of ventricular tachycardia.
Topics: Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Disopyramide; Dose-Response Relationship, Drug; Ele | 1982 |
[Atypical ventricular tachycardia due to disopyramide].
Topics: Aged; Disopyramide; Female; Humans; Isoproterenol; Pyridines; Quinidine; Tachycardia | 1982 |
Ventricular tachyarrhythmias induced by disopyramide and other similar anti-arrhythmic drugs.
Topics: Aged; Disopyramide; Electrocardiography; Female; Follow-Up Studies; Heart Ventricles; Humans; Male; | 1981 |
Disopyramide-induced Torsade de Pointes.
Topics: Aged; Disopyramide; Female; Humans; Isoproterenol; Middle Aged; Pyridines; Tachycardia | 1981 |
Torsade de pointes ventricular tachycardia. A complication of disopyramide shared with quinidine.
Topics: Aged; Disopyramide; Electrocardiography; Female; Heart Ventricles; Humans; Middle Aged; Pyridines; Q | 1981 |
Ventricular pacing in atypical ventricular tachycardia.
Topics: Aged; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; Disopyramide; Electrocardiography; Female; H | 1981 |
Etiology, warning signs and therapy of torsade de pointes. A study of 10 patients.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Disopyramide; Electrocardiography; Female; Heart Ve | 1981 |
Combined effect of verapamil and disopyramide on induction of circus movement tachycardia in patients with pre-excitation.
Topics: Adolescent; Adult; Atrioventricular Node; Disopyramide; Drug Synergism; Female; Heart Conduction Sys | 1981 |
[Ventricular fibrillation during disopyramide treatment].
Topics: Aged; Disopyramide; Electrocardiography; Female; Humans; Male; Middle Aged; Pyridines; Tachycardia; | 1981 |
Unusual dosage of disopyramide.
Topics: Disopyramide; Humans; Injections, Intravenous; Male; Middle Aged; Pyridines; Tachycardia | 1981 |
"Torsade de pointes" - A unique ventricular arrhythmia report of eight cases and review of the literature.
Topics: Aged; Cardiac Pacing, Artificial; Disopyramide; Electrocardiography; Female; Humans; Male; Middle Ag | 1981 |
[Pharmacological therapy and prevention of recurrent ventricular tachycardia].
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Bunaftine; Disopyramide; Humans; Male; Middle Aged; | 1981 |
Ventricular ectopic activity after medical and surgical treatment for recurrent sustained ventricular tachycardia.
Topics: Adult; Aged; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; Disopyramide; Electrocardiography; Fe | 1980 |
Prolonged QT interval, atrioventricular block, and torsade de pointes after antiarrhythmic therapy.
Topics: Aged; Disopyramide; Electrocardiography; Female; Heart; Heart Block; Humans; Lidocaine; Pyridines; T | 1980 |
Respiratory difficulty after use of disopyramide.
Topics: Disopyramide; Drug Hypersensitivity; Heart Ventricles; Humans; Male; Middle Aged; Pyridines; Respira | 1980 |
Ventricular tachycardia with torsade de pointes morphology induced by oral disopyramide.
Topics: Administration, Oral; Disopyramide; Electrocardiography; Female; Humans; Middle Aged; Pyridines; Tac | 1980 |
Potentially dangerous effect of disopyramide on atrioventricular conduction in a patient on digitalis.
Topics: Aged; Arrhythmias, Cardiac; Atrioventricular Node; Digitalis Glycosides; Disopyramide; Female; Heart | 1980 |
[Therapy of ventricular tachyarrhythmia with disopyramid phosphate].
Topics: Adult; Disopyramide; Female; Heart Ventricles; Humans; Male; Middle Aged; Pyridines; Tachycardia | 1980 |
Electrophysiologic characteristics of sustained ventricular tachycardia occurring after repair of tetralogy of fallot.
Topics: Adolescent; Adult; Anti-Arrhythmia Agents; Bundle-Branch Block; Child; Disopyramide; Electrocardiogr | 1980 |
Electrophysiologic effects of disopyramide phosphate on reentrant ventricular arrhythmia in conscious dogs after myocardial infarction.
Topics: Animals; Arrhythmias, Cardiac; Disopyramide; Dogs; Electrophysiology; Heart Conduction System; Heart | 1980 |
Extreme tachycardia complicating the use of disopyramide in atrial flutter.
Topics: Atrial Flutter; Disopyramide; Humans; Male; Middle Aged; Pyridines; Tachycardia | 1980 |
[Paradoxic response to disopyramide and quinidine (author's transl)].
Topics: Adult; Aged; Disopyramide; Female; Heart Valve Diseases; Humans; Male; Middle Aged; Mitral Valve; Py | 1980 |
[Drug therapy of tachyarrhythmias (author's transl)].
Topics: Action Potentials; Adrenergic beta-Antagonists; Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Aprind | 1978 |
The treatment of supraventricular arrhythmias.
Topics: Adrenergic beta-Antagonists; Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Arrhythmia, Sinus; Arrhyt | 1979 |
Clinical studies of Norpace (Part X).
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Cardiac Complexes | 1975 |
Effects of disopyramide on electrophysiological properties of specialized conduction system in man and on accessory atrioventricular pathway in Wolff-Parkinson-White syndrome.
Topics: Adolescent; Adult; Atrial Fibrillation; Atrioventricular Node; Cardiac Complexes, Premature; Child; | 1975 |
Ventricular tachycardia after disopyramide.
Topics: Disopyramide; Humans; Middle Aged; Pyridines; Tachycardia | 1978 |
Ectopic atrial tachycardia on swallowing. Report on favourable effect of verapamil.
Topics: Atrioventricular Node; Atropine; Cardiac Complexes, Premature; Deglutition; Disopyramide; Edrophoniu | 1979 |
Disopyramide--an effective treatment for lignocaine resistant ventricular dysrhythmias.
Topics: Arrhythmias, Cardiac; Cardiac Complexes, Premature; Disopyramide; Female; Humans; Lidocaine; Male; M | 1979 |
Atrial bigeminy with block associated with bradycardia and paroxysmal atrial fibrillation -- an important variant of the tachycardia-bradycardia syndrome.
Topics: Adult; Aged; Atrial Fibrillation; Bradycardia; Cardiac Complexes, Premature; Disopyramide; Electroca | 1979 |
Recurrent ventricular tachycardia in man: evaluation of disopyramide therapy by intracardiac electrical stimulation.
Topics: Administration, Oral; Adult; Aged; Disopyramide; Electric Stimulation; Female; Follow-Up Studies; He | 1979 |
Disopyramide.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Chemical Phenomena; Chemistry; Disopyramide; Heart; He | 1979 |
Treatment of arrhythmias in the Wolff-Parkinson-White syndrome.
Topics: Administration, Oral; Atrial Fibrillation; Disopyramide; Humans; Injections, Intravenous; Lidocaine; | 1979 |
'Bradycardia-tachycardia' syndrome 8 yr after correction of Fallot's tetralogy.
Topics: Adolescent; Arrhythmias, Cardiac; Atrial Flutter; Bradycardia; Child; Child, Preschool; Death, Sudde | 1979 |
Adverse reaction to disopyramide.
Topics: Arrhythmias, Cardiac; Disopyramide; Electrocardiography; Female; Humans; Hypotension; Injections, In | 1979 |
Interaction between disopyramide and practolol.
Topics: Aged; Disopyramide; Drug Interactions; Humans; Male; Middle Aged; Practolol; Pyridines; Tachycardia | 1979 |
Paediatric use of mexiletine and disopyramide.
Topics: Disopyramide; Drug Therapy, Combination; Female; Humans; Infant; Infant, Newborn; Male; Mexiletine; | 1979 |
Disopyramide for cardiac arrhythmias in children.
Topics: Child; Disopyramide; Female; Humans; Pyridines; Tachycardia | 1978 |
Electrode-catheter arrhythmia induction in the selection and assessment of antiarrhythmic drug therapy for recurrent ventricular tachycardia.
Topics: Administration, Oral; Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; D | 1978 |
Recurrent sustained ventricular tachycardia 3. Role of the electrophysiologic study in selection of antiarrhythmic regimens.
Topics: Administration, Oral; Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; D | 1978 |
Atypical ventricular tachycardia as a manifestation of disopyramide toxicity.
Topics: Administration, Oral; Cardiac Pacing, Artificial; Disopyramide; Electrocardiography; Female; Heart C | 1978 |
Electrophysiologic effects of disopyramide phosphate on sinus node function in patients with sinus node dysfunction.
Topics: Adult; Aged; Arrhythmias, Cardiac; Atrial Fibrillation; Atrioventricular Node; Bradycardia; Cardiac | 1979 |
Resistant ventricular tachycardias and recurrent cardiac arrests. 96 episodes.
Topics: Aged; Disopyramide; Electric Countershock; Heart Aneurysm; Humans; Male; Myocardial Infarction; Prop | 1977 |
The antiarrhythmic efficacy of intravenous therapy with disopyramide phosphate.
Topics: Administration, Oral; Adult; Aged; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Disopy | 1977 |
Disopyramide and warfarin interaction.
Topics: Disopyramide; Drug Interactions; Humans; Male; Middle Aged; Pyridines; Tachycardia; Warfarin | 1977 |
Disopyramide in ventricular tachycardia.
Topics: Blood Pressure; Cardiac Output; Disopyramide; Electrocardiography; Heart Rate; Heart Ventricles; Hum | 1976 |
The effects of disopyramide on the human heart: an electrophysiological study.
Topics: Adolescent; Adult; Child; Disopyramide; Electrocardiography; Female; Heart; Heart Conduction System; | 1976 |
Correlation of disopyramide pharmacokinetics with efficacy in ventricular tachyarrhythmia.
Topics: Adult; Aged; Disopyramide; Drug Administration Schedule; Female; Heart Ventricles; Humans; Infusions | 1976 |
Clinical studies of Norpace (Part V).
Topics: Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disopyramide; Drug Evaluation; Female; Hu | 1975 |
Inhibitory effect of moricizine on reperfusion induced tachyarrhythmias in rats--a comparison study with disopyramide and mexiletine.
Topics: Animals; Disopyramide; Heart; Hemodynamics; Male; Mexiletine; Moricizine; Myocardial Infarction; Rat | 1992 |
Repetitive nonsustained monomorphic ventricular tachycardia aborted by methoxamine and sleep "heart rate dependent ventricular tachycardia".
Topics: Adult; Cardiac Pacing, Artificial; Disopyramide; Electrocardiography; Electrocoagulation; Heart Rate | 1991 |
Disopyramide as a negative inotrope in obstructive cardiomyopathy in children.
Topics: Cardiomyopathy, Hypertrophic; Carnitine; Child; Disopyramide; Ductus Arteriosus, Patent; Echocardiog | 1991 |
Clinical features of sustained ventricular tachycardia among various underlying heart diseases.
Topics: Adult; Disopyramide; Electroencephalography; Heart Diseases; Heart Rate; Heart Ventricles; Hemodynam | 1990 |
Periodic changes in cycle length of ventricular tachycardia: a Wenckebach type exit block?
Topics: Bundle of His; Cardiac Complexes, Premature; Cardiac Pacing, Artificial; Disopyramide; Electrocardio | 1986 |
Proarrhythmic effects of antiarrhythmic drugs during programmed ventricular stimulation in patients without ventricular tachycardia.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Cardiac Pacing, Artificial; Disop | 1987 |
Potentially fatal interaction between erythromycin and disopyramide.
Topics: Aged; Aged, 80 and over; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Disopyramide; Drug Inte | 1989 |
Fatal torsade de pointes following jaundice in a patient treated with disopyramide.
Topics: Disopyramide; Female; Humans; Jaundice; Liver; Middle Aged; Tachycardia | 1989 |
Concentration-response relationships of disopyramide in patients with ventricular tachycardia.
Topics: Disopyramide; Dose-Response Relationship, Drug; Electric Stimulation; Electrocardiography; Female; H | 1989 |
[Three cases of Torsades de pointes].
Topics: Adult; Aged; Aged, 80 and over; Disopyramide; Electrocardiography; Female; Humans; Hypokalemia; Male | 1989 |
Combination of disopyramide and mexiletine for better tolerance and additive effects for treatment of ventricular arrhythmias.
Topics: Adult; Aged; Aged, 80 and over; Arrhythmias, Cardiac; Disopyramide; Drug Therapy, Combination; Elect | 1989 |
Failure of corticosteroid therapy to prevent induction of ventricular tachycardia in sarcoidosis.
Topics: Adult; Amiodarone; Cardiac Pacing, Artificial; Cardiomyopathies; Disopyramide; Drug Therapy, Combina | 1989 |
Long-term efficacy of mexiletine alone and in combination with class Ia antiarrhythmic drugs for refractory ventricular arrhythmias.
Topics: Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Disopyramide; Drug Therapy, Combination; Female; | 1988 |
Analysis of antiarrhythmic drug concentrations determined during electrophysiologic drug testing in patients with inducible tachycardias.
Topics: Anti-Arrhythmia Agents; Disopyramide; Electric Stimulation; Electrophysiology; Humans; Procainamide; | 1988 |
A case of arrhythmogenic right ventricular dysplasia with prominent late potential.
Topics: Cardiac Pacing, Artificial; Disopyramide; Drug Therapy, Combination; Electrocardiography; Heart Vent | 1988 |
Danger of use of disopyramide in patients with hypertrophic obstructive cardiomyopathy. An electrophysiologic study.
Topics: Cardiac Pacing, Artificial; Cardiomyopathy, Hypertrophic; Disopyramide; Drug Evaluation; Electrocard | 1988 |
Procainamide, disopyramide and quinidine: discordant antiarrhythmic effects during crossover comparison in patients with inducible ventricular tachycardia.
Topics: Adult; Aged; Disopyramide; Dose-Response Relationship, Drug; Electrocardiography; Female; Humans; Ma | 1987 |
Effects of intravenous disopyramide and quinidine on normal myocardium and on the characteristics of arrhythmias: intraindividual comparison in patients with sustained ventricular tachycardia.
Topics: Adult; Aged; Aged, 80 and over; Cardiac Pacing, Artificial; Coronary Disease; Disopyramide; Electroc | 1987 |
[Electrophysiological studies in 2 patients with chronic persistent atrial tachycardia].
Topics: Adult; Disopyramide; Electrocardiography; Electrophysiology; Female; Humans; Lidocaine; Middle Aged; | 1987 |
Electromechanical dissociation induced by intravenous disopyramide.
Topics: Adolescent; Disopyramide; Female; Heart Arrest; Humans; Infusions, Intravenous; Pulmonary Edema; Tac | 1987 |
Intolerance and ineffectiveness of mexiletine in patients with serious ventricular arrhythmias.
Topics: Cardiac Pacing, Artificial; Disopyramide; Drug Therapy, Combination; Electrocardiography; Electrophy | 1986 |
[Three cases of torsades de pointes due to anti-arrhythmic agents].
Topics: Aged; Aged, 80 and over; Disopyramide; Electrocardiography; Female; Humans; Middle Aged; Procainamid | 1986 |
[Treatment of disturbances of cardiac rhythm using intravenous disopyramide].
Topics: Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Brad | 1974 |
[Panel discussion: Evaluation of the antiarrhythmic drugs and current problems associated with their use in clinical practice (author's transl)].
Topics: Administration, Oral; Ajmaline; Aniline Compounds; Animals; Anti-Arrhythmia Agents; Cardiac Complexe | 1974 |
Compounds related to 4-disopropylamino-2-phenyl-2(2-pyridyl)butyramide. Their synthesis and antiarrhythmic activity.
Topics: Animals; Anti-Arrhythmia Agents; Coronary Vessels; Disopyramide; Dogs; Heart Rate; Ligation; Ouabain | 1974 |